Amount Raised
$50 Million
Round Type
Series B
SuzhouCommerce and ShoppingFood and BeverageHealth CareDescription
Accro Bioscience (Suzhou) Co., LTD. ("Accro Bioscience"), a China-based leading biotechnology company, announced that the company has recently raised over $50 million in an oversubscribed Series B round. The financing was led by Hongtai Aplus with participation from South China Venture Capital, Shenzhen Capital Group, Suzhou Oriza Holdings, and others.
Quick answer
Accro Bioscience raised $50 Million in a Series B round, dated January 5, 2022. Accro Bioscience is based in Suzhou, Jiangsu, China.
- How much did Accro Bioscience raise?
- Accro Bioscience raised $50 Million in a Series B round on January 5, 2022.
- What does Accro Bioscience do?
- Accro Bioscience was established in late 2017 and raised exclusive series A investment from Morningside Ventures.
- Where is Accro Bioscience based and how big is it?
- Accro Bioscience is based in Suzhou, Jiangsu, China.
Source: Fundz verified event record.
Who else raised in Commerce and Shopping and Food and Beverage around the same time
Companies in the same sectors as Accro Bioscience that raised within 45 days of this round, from Fundz verified event records.
- Roundtrip raised an undisclosed amount (Funding Round) on December 14, 2021.
- Oben Electric raised $1M (Seed) on January 24, 2022.
- Foxtrot raised $100M (Series C) on January 11, 2022.
- Hungry Panda raised $130M (Series D) on December 17, 2021.
- Gopuff raised $1.5B (Funding Round) on December 16, 2021.
- BioLumic raised $1.3M (Seed) on December 3, 2021.
Who to call at Accro Bioscience, and when
A new round usually means Accro Bioscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Accro Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Accro Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Accro Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Accro Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansAccro Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.